1340518-89-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Oxetanamine, N-cyclopro is used as a potential pharmaceutical compound for its unique structure and properties, which may contribute to the development of novel drugs with specific therapeutic effects.
Used in Agrochemical Industry:
3-Oxetanamine, N-cyclopro is used as a potential agrochemical compound, with its unique structure and properties potentially contributing to the development of new pesticides or other agrochemical products with specific characteristics.
Used in Materials Science:
3-Oxetanamine, N-cyclopro is used as a potential material in materials science, with its unique structure and properties potentially leading to the development of new materials with specific properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1340518-89-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,0,5,1 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1340518-89:
(9*1)+(8*3)+(7*4)+(6*0)+(5*5)+(4*1)+(3*8)+(2*8)+(1*9)=139
139 % 10 = 9
So 1340518-89-9 is a valid CAS Registry Number.
1340518-89-9Relevant articles and documents
BICYCLIC HETEROARYL AMINE COMPOUNDS AS PI3K INHIBITORS
-
Page/Page column 179, (2016/05/24)
Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q1 is: (i) C1, Br, I, -CN, -CH3, or -CF3; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 Ra and zero to 1 Rb; and R1, R2, R3, R4, R5, R6, Ra, and Rb are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.